Abstract: In patients with extensive bone resorption, implant placement posterior to the mental foramen is a problematic surgical procedure. This paper reports the results in 6 patients (aged 20-61) with edentulous areas in the posterior part of the mandible, in whom 26 Nobelpharma implants were placed, including 17 with transposition of the inferior alveolar nerve allowing the use of implant fixtures of at least 10 mm in length. Subsequent neurosensory function, based on British Medical Research Council definitions, and implant survival rate were examined. In all cases, postoperative numbness occurred in the lower lip and mental area. Three years after surgery, while one patient had completely recovered neurosensory function, five patients still experienced partial numbness, although this was not perceived as a problem by those patients. The implant survival rate was 100% approximately three years after surgery. The results suggest that a higher implant survival rate is likely when longer fixtures are used, but this is also more likely to lead to slight long-term neurosensory dysfunction. (J. Oral Sci. 43, 139-144, 2001) 
Introduction
Osseointegrated implants were developed for prosthetic restoration of lost dentition or edentulous areas of the jaw. Originally, they were mainly used for fully edentulous patients (1), but nowadays they are often used for partially edentulous cases (2) (3) (4) (5) (6) (7) . However, treatment of such posterior partially edentulous areas in the mandible poses two main challenges: firstly, resorption of the alveolar ridge often leaves little bone above the inferior alveolar nerve; secondly, the patient may have an inferior alveolar nerve that is naturally highly placed. To avoid damage to the neurovascular structure in these cases, three options are available. Implant fixtures that are short enough to avoid the mandibular canal can be used; however, shorter fixtures, of 10 mm or less, are less likely to be secure over the long term (8) (9) (10) . Alternatively, longer fixtures can be used if bone grafting and augmentation are performed to increase the height above the mandibular canal, but the disadvantage of this technique is that it requires additional surgery to obtain the bone graft, an additional traumatic procedure. The third possibility is transpositioning of the inferior alveolar nerve during implant surgery. Transpositioning may prevent accidental damage to the nerve during placement of fixtures, and it can give the fixtures better stability by allowing them to be secured to the basal mandibular cortex. The disadvantage of the nerve transpositioning technique is that it can cause complications (11) (12) (13) (14) (15) (16) , such as osteomyelitis (12) (13) (14) (15) (16) , and permanent neurosensory dysfunction (13, 14) . Therefore, it is very important to make sure patients are able to make a fully informed choice of the technique to be used in the implant procedure.
This paper examines neurosensory function and implant survival rate in 6 patients one to three years after implant placement, for 26 fixtures, of which 17 were placed in conjunction with nerve transpositioning at 8 mandibular sites. This allowed fixtures of at least 10 mm length to be used, achieving initial stability of placement from the Table 2 ). In one of the patients (Case 2), the implant site was a bone graft, placed after extraction of multiple impacted teeth. Two patients (Cases 3 and 4) had had teeth removed during the excision of tumors, while Case 1 was congenitally partially edentulous in the implant area. The remaining 2 patients (Cases 5 and 6) were typical Table 1 List of cases Table 2 Type and site of implant fixtures Fig. 1 The neurovascular bundle is exposed and the mental nerve is repositioned laterally. cases of tooth extraction without removal of bone; however, Case 5 had severe resorption of the posterior alveolar ridge, as well as an extremely shallow floor of the mouth. As a result, this patient experienced problems in swallowing and speaking because of a partial denture being displaced by the rising tongue and the entire mouth floor, including the sublingual salivary glands.
In Case 2, 6 months before implant surgery, 4 impacted teeth had been removed from the posterior area of the mandible and the resulting bony defects had been filled with cancellous chip bone grafts. The inferior alveolar nerve had been repositioned during removal of the impacted teeth. In Case 3, an ameloblastoma, as well as associated unerupted permanent molar teeth and teeth germs, had been removed from the posterior area of the mandible to the ramus area when the patient was 4 years old, 16 years previously. In Case 4, 8 years prior to implant surgery a hemimandibulectomy had been performed with removal of the surrounding soft tissue to excise a squamous cell carcinoma located from the gingiva to the mouth floor, resulting in a large defect in the oral cavity that had been reconstructed with a pectoralis major myocutaneous flap.
In 5 of the 6 patients, under general anesthesia, the mental nerve was repositioned laterally (Fig. 1) . In Case 1, under local anesthesia, the nerve was repositioned inferiorly. The implants were placed at the same time as the mental nerve repositioning (Fig. 2) , except in Case 2, in which the implants were placed 6 months later, after healing of the grafts in large bone defects.
In all cases, a buccal incision was made several millimetres below the top of the crest of the alveolar ridge. An additional relief incision was made anteriorly to the mental foramen into the vestibule. A lingual flap and a large buccal flap were reflected, allowing subperiosteal dissection to the mental foramen and identification of the mental foramen and neurovascular bundle. The bundle was then freed from the periosteum. A small circle of holes was drilled through the cortex around the foramen. These holes were connected with a fissure bur and the cortex around the foramen was removed, still attached around the neurovascular bundle. In all patients, the incisive branch of the inferior alveolar nerve had to be cut and removed from the bundle, to allow the bundle to be stretched into its new position. The level and the course of the mandibular canal had been identified in presurgical panoramic radiographs (Fig. 3) . In Case 5, a lateral block osteotomy was performed through the buccal cortical bone, above and below the canal. In Cases 2, 3, 4 and 6, small perforations were made through the buccal bone with a round bur and a continuous incision was made posteriorly with a fissure bur to remove the bone in small pieces, but leaving the cortex of the buccal bone plate unperforated above and below the alveolar canal. In all cases except Case 1, after removal of the lateral cortical bone, a curette was used to remove the cancellous bone lateral to the canal and the canal wall. The neurovascular bundle was gently lifted out of the canal with vessel tape. The fixture sites were then prepared according to standard procedures, with care not to penetrate the basal cortical bone. The implants were then placed under direct visualization through the opening in the buccal bone, to confirm the seating of fixtures in the prepared sites in the buccal cortex. The neurovascular bundle was then repositioned onto the lateral side of the mandible, during which contact with the implants was avoided. The previously removed cortical or cancellous bone was used to fill the empty mandibular canal. Finally, the mucoperiosteal flaps were closed with sutures. Second-stage surgery was performed approximately 6 months after implant placement. Prosthetic treatment was begun approximately 2 weeks later. Immediately after the second-stage surgery, neurosensory tests were performed to assess the level and location of tactile sensation and pain in the lower lip and skin of the mental area in each patient. The cotton-touch technique was used to detect the presence of hypoesthesia, anesthesia and hyperesthesia, and then a pin-prick test was used to detect the location of the disturbed sensation as well as the presence of hypoalgesia, analgesia and hyperalgesia. For each patient, both tests were repeated once a month for six months, and then approximately every 6 months over the following 2 years and 6 months.
Panoramic radiographs were taken immediately after fixing of the prosthesis in each case to check its placement (Fig. 4) . The survival rate for the implant fixtures was checked every year for three years after surgery, by means of a dental x-ray Results At the time of the first neurosensory tests, every patient experienced some degree of disturbance at the site of the nerve transplant. All of the 6 cases displayed anesthesia and analgesia in both the lower lip and mental skin area. Final evaluation of neurosensory function at the three-year stage was conducted using the British Medical Research Council method, as described by Omer (18) .The results are outlined in Table 3 . Even among those patients who reported neurosensory dysfunction at this stage, none complained that it caused them any significant distress.
Functional criteria were used to decide the survival rate of implants in this study, corresponding to the first three of the criteria described in the consensus report by Zarb and Albrektsson (19) . That is: (a) the implant support does not preclude the placement of a planned functional and esthetic prosthesis that is satisfactory to both patient and dentist; (b) there is no pain, discomfort, altered sensation or infection attributable to the implants; and (c) individual unattached implants are immobile when tested clinically. Of the 26 implants in the 6 cases reported here, including 17 fixtures applied with neurovascular transplantation, all were surviving at 4 years after surgery and could be used functionally by each patient.
Discussion
The Branemark implant system presents a number of options: fixtures of varying lengths and diameters can be selected, as well as standard, Mark II, III or IV types of fixture. Selection must take account of the factors affecting the survival rate of implants, including the implant site and the bone volume and quality. Another important factor is the length of fixture used, since longer fixtures provide better initial stability. It has been reported that implants more than 10 mm in length are unlikely to fail, whereas failure rates of up to 12% can occur in implants of 10 mm or less (10). Jemt and Lekholm have reported that the complete failure of implants is significantly correlated with the ratio of 7 mm long fixtures, as well as bone quality (9) .
In the mental region of the mandible, using fixtures of longer than 10 mm is usually not a problem in the anterior region, but it is impossible in the premolar to the molar area when there is severe resorption, because of the proximity to the surface of the mandibular canal. The problem can be overcome by repositioning the inferior alveolar nerve with secure initial placement of longer fixtures into the cortical bone on the border of the mandible. This technique carries the risk of postoperative neurosensory dysfunction, because of possible damage to the nerve during repositioning. Among the 6 patients reported here, 1 had recovered full neurosensory function 12 months after surgery, and 2 others had recovered almost full function at 39 and 41 months. The remaining 3 patients retained small areas of permanent neurosensory dysfunction.
A range of results have been reported for the period of postoperative neurosensory dysfunction following nerve transpositioning, but comparisons are difficult because different surgical techniques, observation periods and neurosensory tests were used (11) (12) (13) (14) . Kan et al. (16) compared the results of 2 nerve transpositioning techniques-block osteotomy including or not including the mental foramen-and reported that the technique involving detachment of the foramen showed a significantly greater incidence of neurosensory disturbance. Using the two-point discrimination test, Rosenquist (12) reported that 5% of patients still experienced altered sensation 18 months after nerve repositioning that included detachment of the mental foramen. Following performance of the same surgical technique, Friberg et al. (17) reported that 30% of patients had neural disturbance 7 months after surgery. Haers and Sailer (13) reported that 12 months after surgery involving the lateralisation of the inferior alveolar nerve and simultaneous insertion of implants, 76.5% of patients experienced slight paresthesia. It has been said that the advantage of the nerve transpositioning technique is that it allows longer implant fixtures to be used, leading to higher implant survival rates. Various authors have reported the survival rates of implants using fixtures of less than 10 mm placed without nerve transpositioning (3, 7). Rosenquist (12) (5) as 98% at 5 years, and by Zarb and Schmidt (4) as 92.2% at 5 years. In the cases reported here, all of the 17 implants placed in conjunction with nerve transpositioning were surviving at 3 years, as were the 9 other fixtures placed without nerve transpositioning.
In conclusion, it appears that there may be only a small difference in the survival rate of fixtures of varying lengths. It is also unclear whether there is a statistically significant increase in the risk of permanent neurosensory dysfunction following nerve transpositioning. This makes it difficult to advise patients who require implants in severely resorbed posterior areas of the mandible. However, the results described in this paper, together with the indications reported by other authors, suggest that a higher implant survival rate is likely to be achieved when longer fixtures are used with nerve transpositioning, but this is more likely to lead to long-term, though slight, neurosensory dysfunction. In addition, when patients are informed before the operation that neurosensory dysfunction may result, they are less likely to regard that dysfunction as problematic if it occurs.
